Use of zidovudine and interferon alfa with chemotherapy improves survival in both acute and lymphoma subtypes of adult T-cell leukemia/lymphoma

Journal of Clinical Oncology

Volumn 29, Issue 35, 2011, Pages 4696-4701

  Hodson, Andrew ^a   Crichton, Siobhan ^b   Montoto, Silvia ^c   Mir, Naheed ^d   Matutes, Estella ^e   Cwynarski, Kate ^f   Kumaran, Thurai ^g   Ardeshna, Kirit M ^h   Pagliuca, Antonio ⁱ   Taylor, Graham P ^j   Fields, Paul A ⁱ  

^a IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d UNIVERSITY HOSPITAL LEWISHAM   (United Kingdom)

^e INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^f ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

^g NORTH MIDDLESEX UNIVERSITY HOSPITAL   (United Kingdom)

^h UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

ⁱ KING'S COLLEGE LONDON   (United Kingdom)

^j IMPERIAL COLLEGE LONDON   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALPHA INTERFERON; ANTINEOPLASTIC AGENT; CARBOPLATIN; COTRIMOXAZOLE; CYTARABINE; DACLIZUMAB; DAPSONE; FLUCONAZOLE; GEMCITABINE; ITRACONAZOLE; METHOTREXATE; ZIDOVUDINE;

ACUTE LEUKEMIA; ADULT; AGED; ANEMIA; ANTIVIRAL THERAPY; ARTICLE; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CHEMOPROPHYLAXIS; DRUG MEGADOSE; DRUG WITHDRAWAL; FEMALE; HEART FAILURE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; LACTIC ACIDOSIS; MAJOR CLINICAL STUDY; MALE; NEPHROTIC SYNDROME; NEUTROPENIA; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; T CELL LEUKEMIA; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT RESPONSE;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; HUMANS; INTERFERON-ALPHA; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; YOUNG ADULT; ZIDOVUDINE;

EID: 83255171001     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.35.5578     Document Type: Article

References (29)

1. IARC Monographs on the Evaluation of Carcinogenic Risk to Humans: Human Immunodeficiency Viruses and Human T-Cell Lymphotropic Viruses. Lyon, France, IARC Press, 1996
2. Tosswill JH, Taylor GP, Tedder RS, et al.: HTLV-I/II associated disease in England and Wales, 1993-7: Retrospective review of serology requests. BMJ 320:611-612, 2000 (Pubitemid 30175831)
3. Hanchard B: Adult T-cell leukemia/lymphoma in Jamaica: 1986-1995. J Acquir Immune Defic Syndr Hum Retrovirol 13:S20-S25, 1996 (suppl 1)
4. Tajima K: The 4th nation-wide study of adult T-cell leukemia/lymphoma (ATL) in Japan: Estimates of risk of ATL and its geographical and clinical features-The T- and B-cell Malignancy Study Group. Int J Cancer 45:237-243, 1990
5. Murphy EL, Hanchard B, Figueroa JP, et al.: Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I. Int J Cancer 43:250-253, 1989 (Pubitemid 19062419)
6. Iwanaga M, Watanabe T, Utsunomiya A, et al.: Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: A nationwide prospective study in Japan. Blood 116:1211-1219, 2010
7. Shimoyama M: Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemialymphoma: A report from the Lymphoma Study Group (1984-87). Br J Haematol 79:428-437, 1991
8. Dougan S, Payne LJ, Tosswill JH, et al.: HTLV infection in England and Wales in 2002: Results from an enhanced national surveillance system. Commun Dis Public Health 7:207-211, 2004
9. Gibbs WN, Lofters WS, Campbell M, et al.: Non-Hodgkin lymphoma in Jamaica and its relation to adult T-cell leukemia-lymphoma. Ann Intern Med 106:361-368, 1987 (Pubitemid 17029485)
10. Deardren C, Corbin D, Prussia P, et al.: Clinical and laboratory features of adult T-cell leukaemia lymphoma in Barbados. Leuk Lymphoma 23:561-565, 1996 (Pubitemid 27029667)
11. Takatsuki K: Adult T-cell leukemia. Intern Med 34:947-952, 1995
12. Takatsuki K, Matsuoka M, Yamaguchi K: Adult T-cell leukemia in Japan. J Acquir Immune Defic Syndr Hum Retrovirol 13:S15-S19, 1996 (suppl 1)
13. Catovsky D, Greaves MF, Rose M, et al.: Adult T-cell lymphoma-leukaemia in blacks from the West Indies. Lancet 1:639-643, 1982 (Pubitemid 12179932)
14. Matutes E, Catovsky D: ATL of Caribbean origin, in Takatsuki K (ed): Adult T-Cell Leukaemia. Oxford, United Kingdom, Oxford University Press, 1994, pp 113-138
15. Pawson R, Richardson DS, Pagliuca A, et al.: Adult T-cell leukemia/lymphoma in London: Clinical experience of 21 cases. Leuk Lymphoma 31:177-185, 1998 (Pubitemid 28428761)
16. Matutes E, Taylor GP, Cavenagh J, et al.: Interferon alpha and zidovudine therapy in adult T-cell leukaemia lymphoma: Response and outcome in 15 patients. Br J Haematol 113:779-784, 2001 (Pubitemid 32524403)
17. Simpson S, Thanigaikumar M, Taylor G, et al.: Combination chemotherapy with CHOP-daclizumab in HTLV-1 associated adult T-cell leukaemia/lymphoma. Blood 108, 2006 (abstr 2750)
18. Gill PS, Harrington W Jr, Kaplan MH, et al.: Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine. N Engl J Med 332:1744-1748, 1995
19. Hermine O, Bouscary D, Gessain A, et al.: Brief report: Treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfa. N Engl J Med 332:1749-1751, 1995
20. Yamada Y, Tomonaga M, Fukuda H, et al.: A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303. Br J Haematol 113:375-382, 2001 (Pubitemid 32523141)
21. Bazarbachi A, Plumelle Y, Carlos Ramos J, et al.: Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia/lymphoma showing improved survival in the leukemic subtypes. J Clin Oncol 28:4177-4183, 2010
22. Tsukasaki K, Utsunomiya A, Fukuda H, et al.: VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. J Clin Oncol 25:5458-5464, 2007 (Pubitemid 350232223)
23. Taylor GP, Matsuoka M: Natural history of adult T-cell leukemia/lymphoma and approaches to therapy. Oncogene 24:6047-6057, 2005 (Pubitemid 43086122)
24. Ratner L, Harrington W, Feng X, et al.: Human T cell leukemia virus reactivation with progression of adult T-cell leukemia-lymphoma. Plos ONE 4:e4420, 2009
25. Datta A, Bellon M, Sinha-Datta U, et al.: Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence. Blood 108:1021-1029, 2006 (Pubitemid 44154640)
26. Ramos JC, Ruiz P Jr, Ratner L, et al.: IRF-4 and c-Rel expression in antiviral-resistant adult T-cell leukemia/lymphoma. Blood 109:3060-3068, 2007 (Pubitemid 46482107)
27. Ishitsuka K, Suzumiya J, Aoki M, et al.: Therapeutic potential of arsenic trioxide with or without interferon-alpha for relapsed/refractory adult T-cell leukemia/lymphoma. Haematologica 92:719-720, 2007 (Pubitemid 350144285)
28. Kchour G, Tarhini M, Kooshyar MM, et al.: Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL). Blood 113:6528-6532, 2009
29. Yamamoto K, Utsunomiya A, Tobinai K, et al.: Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma. J Clin Oncol 28:1591-1598, 2010